Search details
1.
Validation of the BOADICEA model in a prospective cohort of BRCA1/2 pathogenic variant carriers.
J Med Genet
; 2024 Jun 04.
Article
in English
| MEDLINE | ID: mdl-38834293
2.
Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium.
Breast Cancer Res
; 25(1): 72, 2023 06 20.
Article
in English
| MEDLINE | ID: mdl-37340476
3.
Boosting GWAS using biological networks: A study on susceptibility to familial breast cancer.
PLoS Comput Biol
; 17(3): e1008819, 2021 03.
Article
in English
| MEDLINE | ID: mdl-33735170
4.
Gene- and pathway-level analyses of iCOGS variants highlight novel signaling pathways underlying familial breast cancer susceptibility.
Int J Cancer
; 148(8): 1895-1909, 2021 04 15.
Article
in English
| MEDLINE | ID: mdl-33368296
5.
Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study.
Am J Obstet Gynecol
; 225(1): 51.e1-51.e17, 2021 07.
Article
in English
| MEDLINE | ID: mdl-33493488
6.
A new hybrid record linkage process to make epidemiological databases interoperable: application to the GEMO and GENEPSO studies involving BRCA1 and BRCA2 mutation carriers.
BMC Med Res Methodol
; 21(1): 155, 2021 07 29.
Article
in English
| MEDLINE | ID: mdl-34325649
7.
Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants.
Genet Med
; 22(10): 1653-1666, 2020 10.
Article
in English
| MEDLINE | ID: mdl-32665703
8.
Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriers.
Breast Cancer Res
; 20(1): 28, 2018 04 17.
Article
in English
| MEDLINE | ID: mdl-29665859
9.
Telomere length, ATM mutation status and cancer risk in Ataxia-Telangiectasia families.
Carcinogenesis
; 38(10): 994-1003, 2017 10 01.
Article
in English
| MEDLINE | ID: mdl-28981872
10.
FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor.
Hum Mol Genet
; 24(18): 5345-55, 2015 Sep 15.
Article
in English
| MEDLINE | ID: mdl-26130695
11.
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
JAMA
; 317(23): 2402-2416, 2017 06 20.
Article
in English
| MEDLINE | ID: mdl-28632866
12.
Germline BAP1 mutations predispose to renal cell carcinomas.
Am J Hum Genet
; 92(6): 974-80, 2013 Jun 06.
Article
in English
| MEDLINE | ID: mdl-23684012
13.
Mutation analysis of PALB2 gene in French breast cancer families.
Breast Cancer Res Treat
; 154(3): 463-71, 2015 Dec.
Article
in English
| MEDLINE | ID: mdl-26564480
14.
A new scoring system in cancer genetics: application to criteria for BRCA1 and BRCA2 mutation screening.
J Med Genet
; 51(2): 114-21, 2014 Feb.
Article
in English
| MEDLINE | ID: mdl-24343917
15.
Safety of the Breast Cancer Adjuvant Radiotherapy in Ataxia-Telangiectasia Mutated Variant Carriers.
Cancers (Basel)
; 16(7)2024 Apr 05.
Article
in English
| MEDLINE | ID: mdl-38611095
16.
Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk.
medRxiv
; 2024 Mar 04.
Article
in English
| MEDLINE | ID: mdl-38496424
17.
Contralateral breast cancer risk in patients with breast cancer and a germline-BRCA1/2 pathogenic variant undergoing radiation.
J Natl Cancer Inst
; 115(11): 1318-1328, 2023 11 08.
Article
in English
| MEDLINE | ID: mdl-37369040
18.
Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1 and BRCA2 mutations carrier cohort (GENEPSO).
Breast Cancer Res
; 14(4): R99, 2012 Jul 03.
Article
in English
| MEDLINE | ID: mdl-22762150
19.
Variants in the netrin-1 receptor UNC5C prevent apoptosis and increase risk of familial colorectal cancer.
Gastroenterology
; 141(6): 2039-46, 2011 Dec.
Article
in English
| MEDLINE | ID: mdl-21893118
20.
Oral Contraceptive Use in BRCA1 and BRCA2 Mutation Carriers: Absolute Cancer Risks and Benefits.
J Natl Cancer Inst
; 114(4): 540-552, 2022 04 11.
Article
in English
| MEDLINE | ID: mdl-35048954